Houston, TX 的 主動脈瓣狹窄 臨床試驗
7 項針對 主動脈瓣狹窄 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
招募中觀察性研究
- Baylor Saint Luke's (The Texas Heart Institute), Houston
- Houston Methodist Hospital, Houston
- University of Texas Health Science Center at Houston, Houston
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
招募中
- University of Texas Memorial Hermann, Houston
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
招募中2/3 期
- Houston Methodist Hospital, Houston
- University of Texas Medical Branch - Galveston, Houston
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
招募中2 期
- Texas Heart Institute, Houston
- Orion Medical, Houston
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
招募中
- HCA Houston Healthcare Medical Center, Houston
- The University of Texas Health Science Center, Houston
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
招募中
- HCA Houston Healthcare Medical Center, Houston
PARTNER 3 Trial - Aortic Valve-in-Valve
招募中
- The University of Texas Health Science Center at Houston, Houston
其他城市的 主動脈瓣狹窄 試驗
- Boston, MA10 項研究
- San Francisco, CA9 項研究
- New York City, NY9 項研究
- Cleveland, OH8 項研究
- Cincinnati, OH7 項研究
- Mountain View, CA7 項研究
- Rochester, MN6 項研究
- Los Angeles, CA6 項研究
- Pittsburgh, PA6 項研究
- Nashville, TN6 項研究
- Newark, NJ6 項研究
- Chicago, IL6 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。